X-80676917-C-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_153252.5(BRWD3):c.5101G>A(p.Gly1701Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000715 in 1,203,059 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 280 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_153252.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRWD3 | NM_153252.5 | c.5101G>A | p.Gly1701Arg | missense_variant | 41/41 | ENST00000373275.5 | NP_694984.5 | |
BRWD3 | XM_005262113.4 | c.4951G>A | p.Gly1651Arg | missense_variant | 40/40 | XP_005262170.1 | ||
BRWD3 | XM_017029384.2 | c.3889G>A | p.Gly1297Arg | missense_variant | 30/30 | XP_016884873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRWD3 | ENST00000373275.5 | c.5101G>A | p.Gly1701Arg | missense_variant | 41/41 | 1 | NM_153252.5 | ENSP00000362372.4 |
Frequencies
GnomAD3 genomes AF: 0.000307 AC: 34AN: 110728Hom.: 0 Cov.: 22 AF XY: 0.000273 AC XY: 9AN XY: 32972
GnomAD3 exomes AF: 0.000380 AC: 69AN: 181491Hom.: 0 AF XY: 0.000404 AC XY: 27AN XY: 66863
GnomAD4 exome AF: 0.000756 AC: 826AN: 1092280Hom.: 0 Cov.: 29 AF XY: 0.000757 AC XY: 271AN XY: 358118
GnomAD4 genome AF: 0.000307 AC: 34AN: 110779Hom.: 0 Cov.: 22 AF XY: 0.000272 AC XY: 9AN XY: 33033
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 18, 2014 | The p.G1701R variant (also known as c.5101G>A), located in coding exon 41 of the BRWD3 gene, results from a G to A substitution at nucleotide position 5101. The glycine at codon 1701 is replaced by arginine, an amino acid with dissimilar properties. This variant was previously reported in the SNPDatabase as rs200751676. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele was absent out of 2443 total male alleles studied. This amino acid position is not conserved on species alignment. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 29, 2015 | - - |
Intellectual disability Benign:1
Likely benign, no assertion criteria provided | clinical testing | Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille | Jan 01, 2019 | - - |
Intellectual disability, X-linked 93 Benign:1
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at